BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21826954)

  • 1. [Obesity, insulin resistance and type 2 diabetes: risk factors for breast cancer].
    Scheen AJ; Beck E; De Flines J; Rorive M
    Rev Med Liege; 2011; 66(5-6):238-44. PubMed ID: 21826954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
    Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular links between obesity and breast cancer.
    Lorincz AM; Sukumar S
    Endocr Relat Cancer; 2006 Jun; 13(2):279-92. PubMed ID: 16728564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, type 2 diabetes and risk of digestive cancer.
    Hillon P; Guiu B; Vincent J; Petit JM
    Gastroenterol Clin Biol; 2010 Oct; 34(10):529-33. PubMed ID: 20864282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, adipocytokines, and insulin resistance in breast cancer.
    Rose DP; Komninou D; Stephenson GD
    Obes Rev; 2004 Aug; 5(3):153-65. PubMed ID: 15245384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
    Vona-Davis L; Howard-McNatt M; Rose DP
    Obes Rev; 2007 Sep; 8(5):395-408. PubMed ID: 17716297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the hyperinsulinaemia-diabetes-cancer link for preventive efforts.
    Moore MA; Park CB; Tsuda H
    Eur J Cancer Prev; 1998 Apr; 7(2):89-107. PubMed ID: 9818771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications.
    Simone V; D'Avenia M; Argentiero A; Felici C; Rizzo FM; De Pergola G; Silvestris F
    Oncologist; 2016 Apr; 21(4):404-17. PubMed ID: 26865587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper abdominal obesity, insulin resistance and breast cancer risk.
    Stoll BA
    Int J Obes Relat Metab Disord; 2002 Jun; 26(6):747-53. PubMed ID: 12037643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin: taking away the candy for cancer?
    Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
    Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulinemia and the risk of breast cancer and its relapse.
    Formica V; Tesauro M; Cardillo C; Roselli M
    Diabetes Obes Metab; 2012 Dec; 14(12):1073-80. PubMed ID: 22537210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes, insulin, insulin analogues, and cancer].
    Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
    Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy balance adiposity and breast cancer - energy restriction strategies for breast cancer prevention.
    Harvie M; Howell A
    Obes Rev; 2006 Feb; 7(1):33-47. PubMed ID: 16436101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation.
    Nunez NP; Oh WJ; Rozenberg J; Perella C; Anver M; Barrett JC; Perkins SN; Berrigan D; Moitra J; Varticovski L; Hursting SD; Vinson C
    Cancer Res; 2006 May; 66(10):5469-76. PubMed ID: 16707476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy.
    Vona-Davis L; Rose DP
    Curr Diabetes Rev; 2012 Mar; 8(2):116-30. PubMed ID: 22268396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer.
    Crujeiras AB; Díaz-Lagares A; Carreira MC; Amil M; Casanueva FF
    Free Radic Res; 2013 Apr; 47(4):243-56. PubMed ID: 23409968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer.
    Ferguson RD; Gallagher EJ; Scheinman EJ; Damouni R; LeRoith D
    Vitam Horm; 2013; 93():51-98. PubMed ID: 23810003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.